Enorama Pharma enters into agreements regarding screening study within Cough & Cold

The cost of this initial analysis is covered by MediiGum LLC.

Enorama Pharma has entered into an agreement with the company MediiGum LLC to conduct a screening study of active substances within the therapy area Cough & Cold. The preliminary study investigates the suitability of the active substances for administration via chewing gum and the Company's ChewMed®-technology. The cost of this initial analysis is covered by MediiGum LLC.

Read the full press release in Swedish